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Osteoarthritis of the knee causes pain, limits activity, and
impairs quality of life. Although it cannot be cured, advances
in understanding and treatment have improved the outlook for
people with this condition. This review will outline evidence
for management and emphasise the importance of a patient
centred multidisciplinary approach, conservative non-drug
interventions, judicious use of drugs, and appropriate surgical
referral.
What is osteoarthritis and how common
is it?
Osteoarthritis is a painful chronic joint disease characterised by
structural changes to the whole joint, including loss of articular
cartilage, development of osteophytes, synovial inflammation,
subchondral bone changes, meniscal damage, muscle weakness,
and ligamentous laxity. It results from a complex interplay of
genetic, metabolic, biomechanical, and biochemical factors. At
the knee, osteoarthritis most commonly affects the medial
tibiofemoral and patellofemoral joint compartments.
The reported incidence and prevalence of osteoarthritis of the
knee varies, depending on population characteristics and disease
definition. There are few population based incidence studies.
The longest and most recent reported a relatively low annual
cumulative radiographic incidence of 2.3% in middle aged
women over a 15 year period.w1 In a systematic review,
prevalence rates of radiographic disease ranged from 4.3% to
78.6%, whereas rates were lower for symptomatic disease
(3.2-13.5%).w2
Who gets osteoarthritis?
Osteoarthritis of the knee is more common in women and older
people.w3 Racial and ethnic differences also exist, with higher
rates in black and Chinese people than in white
people.w3Systemic and local risk factors have been identified
(fig 1⇓), with obesity and joint injury (particularly anterior
cruciate ligament and meniscal injuries in sports people) being
important modifiable factors. This last risk factor means that a
proportion of those affected will be young active people in their
30s and 40s. Public health strategies targeted towards weight
reduction and prevention of knee injuries could prevent large
numbers of people developing the condition. Strong longitudinal
evidence shows that knee malalignment (varus for medial knee
osteoarthritis and valgus for lateral knee osteoarthritis) and
obesity increase the risk of structural disease progression in
those with established disease.w3 In contrast, few studies have
examined risk factors for functional decline and disability.
How is osteoarthritis diagnosed?
Clinically, osteoarthritis is diagnosed on the basis of a history
and physical examination. Radiography is used to confirm
clinical suspicion and exclude other conditions. When
radiography is used along with physical examination, sensitivity
and specificity are 91% and 86%, respectively.w4 The
osteoarthritis task force of the European League against
Rheumatism suggests six criteria for a confident clinical
diagnosis of osteoarthritis of the knee (box 1).1
Magnetic resonance imaging does not help in decisions about
current interventions for osteoarthritis of the knee and should
not be performed unless it will change management. This test
may be useful when considering rare differential diagnoses such
as osteochondritis dissecans, pigmented villonodular synovitis,
or avascular necrosis (box 2). Inappropriate use of magnetic
resonance imaging can lead to increased detection of incidental
meniscal tears, which are common in older people,w5 and result
in unnecessary arthroscopic knee surgery.
What are the principles of prevention and
management?
Management of osteoarthritis of the knee has traditionally
focused on treating pain and disability. However, a broader
approach that includes prevention (reduction of risk
factors—especially overweight or obesity, joint injury, and
potentially smoking and vitamin D deficiency—to reduce
disease incidence) and interventions that slow down disease
progression is now recommended. Optimalmanagement requires
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Summary points
Osteoarthritis is a chronic disease; management should be patient centred and coordinated, with attention to modifiable risk factors and
comorbidities
Focus on conservative non-drug treatment, particularly exercise; for overweight or obese patients weight loss is recommended
Management should be evidence based; do not use interventions with high cost and risk that outweigh their benefits
Use paracetamol or non-steroidal anti-inflammatory drugs for pain relief, with due attention to precautions and contraindications
Refer patients to a physiotherapist for exercise, manual therapy, and gait aids; orthotist for bracing; psychologist for cognitive behavioural
therapy; and dietitian for nutritional advice
Do not use arthroscopy for pain management; refer patients for joint replacement only when symptoms are severe and other treatments
have failed
Sources and selection criteria
We used recently published clinical guidelines for the management of osteoarthritis of the knee from the Osteoarthritis Research Society
International, American College of Rheumatology, National Institute for Health and Clinical Excellence, European League against Rheumatism,
American Academy of Orthopaedic Surgeons, Royal Australian College of General Practitioners, and the Ottawa Panel. We also searched
the Cochrane Database of Systematic Reviews (without time limits) and performed PubMed and Embase searches (January 2008 to March
2012) using the keywords “knee” and “osteoarthritis”. We selected high quality systematic reviews, meta-analyses, and large randomised
controlled trials. When such studies were unavailable, we considered relevant small randomised controlled trials, cohort studies, and
observational studies.
Box 1 European League against Rheumatism recommendations on the diagnosis of knee osteoarthritis
These recommendations focus on six clinical signs and symptoms identified by a Delphi consensus approach across 12 countries.1
Symptoms
Persistent knee pain
Limited knee stiffness (<30 min)
Reduced function
Signs
Crepitus
Restricted movement
Bony enlargement
Box 2 Differential diagnosis of knee pain and indications for magnetic resonance imaging (MRI)
Common conditions that typically do not require MRI
Pes anserine bursitis
Iliotibial band friction syndrome
Patellar tendinosis
Patellofemoral pain syndrome
Prepatellar bursitis
Semimembranosus bursitis
Uncommon conditions where MRI may be helpful
Osteochondritis dissecans: usually presents with pain, swelling, and mechanical symptoms including catching, locking, popping noises,
and giving way
Pigmented villonodular synovitis: usually presents with sudden onset, unexplained joint swelling, and pain, with swelling disproportionate
to the amount of pain
Avascular necrosis: often asymptomatic early on with increasing joint pain as structure deteriorates; risk factors include long term steroid
use, excessive alcohol use, clotting disorders
a combination of conservative non-drug and drug treatments,
with surgery reserved for severe clinical disease with structural
changes.2Because the condition is chronic, education, self help,
and patient driven treatments are important.
Holistic assessment of the patient’s medical, social, and
psychological needs can enable a tailored approach to treatment
formulated in partnership with the patient (table⇓).3 4 The risks
and benefits of treatment options should be communicated to
patients in ways that can be understood. Periodic monitoring
(every three months) for effects of treatment on pain, function,
psychological status, and quality of life—as well as metrics of
intervention, including body weight and muscle strength—can
maximise treatment adherence and enable management to be
tailored to the patient’s changing needs.4
What are the conservative treatment
options?
To ensure safe and effective delivery of the many conservative
non-drug treatments suitable for osteoarthritis of the knee, a
multidisciplinary approach is needed, with judicious referral to
allied health practitioners according to the patient’s needs and
the healthcare setting (table). Core conservative treatments for
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all patients include education and exercise, with weight loss for
those who are overweight or obese.
Education about the disease process, pain mechanisms, and
treatment options can be delivered in various ways, including
informal discussion with the healthcare provider, provision of
written materials, support groups, national association websites,
and referral to self management programmes. However,
meta-analyses show that in isolation these programmes have
negligible effect sizes.5
Exercise is essential for all patients, irrespective of disease
severity, age, comorbidity, pain severity, or disability.
Meta-analyses show small to moderate effect sizes with exercise
for pain and function,6 similar to those achieved with analgesics
and non-steroidal anti-inflammatory drugs (NSAIDs).5 A
Cochrane review found that, compared with fewer than 12
supervised exercise sessions, 12 or more directly supervised
exercise sessions with a health professional significantly
improved pain (effect size 0.46) and function (0.45) (pain 0.28,
function 0.23).6 Local muscle strengthening and general aerobic
exercise are recommended,2 4 7 whereas aquatic exercise may
be better for people with serious mobility and functional
limitations or those who cannot exercise on land.w6 Tai chi is
gaining popularity, and a systematic review of randomised
controlled trials (RCTs) found encouraging but limited and not
necessarily high quality evidence of benefit.w7Although exercise
is beneficial, sports that involve twisting and high impact
activities such as running should be avoided. Instead, advise
younger active people who develop osteoarthritis after a knee
injury to modify their activity and participate in low impact
sports such as cycling, rowing, swimming, and deep water
running. Finally, adherence to exercise and physical activity is
vital for long term benefits (box 3).8
A meta-analysis of a limited number of RCTs showed that a
reduction in body weight of at least 5% at a rate of 0.24% per
week over 20 weeks in overweight and obese people improved
pain and disability, although the effect sizes were small
(0.20-0.23).9 A high quality RCT also showed that weight loss
improved all cause mortality in overweight or obese people with
knee osteoarthritis by 10%.w8 Furthermore, a computer
simulation model of knee osteoarthritis and obesity using
national US census and obesity data showed that a 0.6 unit
reduction in mean body mass index (about 1.7 kg in a 1.7 m tall
person) would reduce total knee replacements over the remaining
lifespan of this population by 1.9%.w9 Ottawa Panel guidelines
have been developed specifically for overweight or obese people
with osteoarthritis. These graded recommendations are based
on a systematic review of evidence (RCTs, controlled clinical
trials, cohort studies, and head to head studies) that consider
the strength of evidence and rigour of experimental design. The
review showed that, compared with either intervention alone or
control, a combination of physical activity (aerobic exercise
plus or minus strength training) and a weight reducing diet
produced the most benefit on a range of clinical outcomes, with
highest level recommendations for pain relief, functional status,
strength, and quality of life.10 The panel recommends weight
loss before weight bearing exercise is implemented to maintain
joint integrity. A recent longitudinal study found that significant
weight loss is accompanied by loss of leg muscle tissue and
strength, so strengthening exercise should be undertaken
alongside weight loss strategies.w10
A variety of other interventions may be useful depending on
the patient’s presentation and preferences. Despite gait aids
being widely recommended, the first RCT of cane use has only
just been published.w11 It found that compared with no cane use,
two months of daily cane use reduced pain and improved
function (effect size 0.18 and 0.13, respectively). A recent RCT
found that, compared with flat insoles, lateral wedge insoles
had no effect on symptoms or cartilage loss over 12 months.11
RCTs show that unloading knee braces can improve
malalignment and improve symptoms,12 w12 but their use in
clinical practice has been limited by important patient factors
including adherence, comfort, and fitting.w12 A small number
of RCTs have shown that medially directed knee taping by a
physiotherapist can reduce pain.7 A systematic review of 12
RCTs found that the addition of passive manual mobilisations
to an exercise programme produced superior pain relief (effect
size 0.69) to strengthening exercise (0.38) or combination
exercise (0.34) alone.13
Because psychological factors can influence the pain experience,
interventions such as cognitive behavioural therapy (training in
pain coping skills) are recommended for some patients.7
However, the evidence is limited; a meta-analysis identified
few clinical trials of cognitive behavioural therapy in knee
arthritis and the effect size for pain reduction was small (0.18).14
The number of RCTs of acupuncture in the treatment of
osteoarthritis of the knee has increased. These show significant
and clinically relevant reductions in pain, although much of this
is due to expectation (placebo effects).15 American College of
Rheumatology guidelines recommend acupuncture only for
patients with moderate to severe pain who are candidates for
joint replacement but are unwilling or unable to have the
operation.7 Similar recommendations were made for
transcutaneous electrical nerve stimulation.7
What drugs are available to control pain
in osteoarthritis of the knee?
Analgesics can be useful. Paracetamol (acetaminophen), in
doses of up to 4 g/day, is currently recommended for the initial
treatment of mild to moderate pain in osteoarthritis of the knee.5
However, because of concerns about the risk of hepatotoxicity,
an advisory committee of the US Food and Drug Administration
recently recommended that themaximum adult daily dose should
be less than 4 g/day and that the content in single doses of over
the counter analgesics be limited to 650 mg.w13 A systematic
review of RCTs that provided a head to head comparison
between paracetamol and NSAIDs showed better efficacy and
patient preference for NSAIDs, although side effects were
greater.5 No good evidence supports one NSAID over another
with regard to efficacy for symptoms. Cardiovascular safety
concerns with highly potent cyclo-oxygenase-2 selective
inhibitors have led to some of these drugs being taken off the
market and have drawn attention to similar concerns for
non-selective NSAIDs as well as gastrointestinal safety risks.
Practitioners must therefore be aware of the warnings,
precautions, and contraindications associated with the use of
these agents. If it is deemed necessary to prescribe an oral
NSAID for people with risk factors for gastrointestinal toxicity,
consider the use of a cyclo-oxygenase-2 selective inhibitor or
combined use of a non-selective NSAIDwith a gastroprotective
agent (proton pump inhibitor). For people over 75 years, the
American College of Rheumatology strongly recommends the
use of topical rather than oral NSAIDs (box 4).7
Because some people with osteoarthritis of the knee also have
depression and neuropathic pain symptoms (shooting or burning
pain, pins and needles), the role of centrally active agents,
including selective serotonin and noradrenaline reuptake
inhibitors, has been of interest. At this stage, duloxetine is the
only agent to have been examined in a high quality RCT.16 In
this study, 65% of participants in the duloxetine group reported
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Box 3 Strategies to facilitate long term adherence to exercise and physical activity
Exercise is a core treatment, yet adherence is difficult to maintain and research has shown that lack of adherence limits the long term
effectiveness of exercise
• Educate patients about the disease and the benefits of exercise
• Develop the exercise or physical activity plan with the patient and vary to maintain interest and enthusiasm
• Use a graded progressive exercise or physical activity programme and ensure that pain and discomfort are not excessive during or
after exercise
• Initiate exercise under expert instruction and supervise exercise sessions if possible
• Supplement face to face instruction with other materials, such as written handouts, videos or DVDs, and online demonstrations
• Increase self efficacy by incorporating behavioural techniques, such as goal setting, positive reinforcement, use of an exercise contract,
and self monitoring using a diary or pedometer
• Include partners and family in the exercise programme and garner support from family and friends
• Monitor over the long term with periodic reassessment by a health professional
Box 4 Drugs for the management of knee osteoarthritis7
First line drugs
Paracetamol
If using full dose (4 g/day), counsel patient to avoid other products containing paracetamol, including over the counter cold remedies
Non-steroidal anti-inflammatory drugs (NSAIDs)
Be aware of contraindications and gastrointestinal and cardiovascular safety concerns
Consider use of topical NSAIDs in people over 75 years
Discourage the use of NSAIDs in people with a history of symptomatic or complicated upper gastrointestinal ulcer. If necessary, consider
either a cyclo-oxygenase-2 selective inhibitor plus proton pump inhibitor or naproxen combined with a proton pump inhibitor
In patients taking low dose aspirin for cardioprotection who are prescribed oral NSAIDs, a non-selective NSAID other than ibuprofen is
recommended, together with a proton pump inhibitor
Do not use oral NSAIDs in patients with chronic kidney disease stage IV or V (estimated glomerular filtration rate <30 ml/min). The
decision to use an oral NSAID should be made on an individual basis in patients with chronic kidney disease stage III (estimated
glomerular filtration rate 30-59 ml/min)
Second line treatment (persistent symptoms despite optimal conservative treatment and use of first line agents)
Opioids
Consider use when NSAIDs are contraindicated and paracetamol is ineffective
Start at a low dose and titrate as needed and tolerated
Side effects—including nausea, constipation, dizziness, sleepiness, and vomiting—are common
Intra-articular corticosteroid injections
May be performed every three months but generally maximum of around four injections
Cautionary note regarding short duration of efficacy (one to two weeks on average)
Centrally active agents
If concomitant depression and neuropathic pain symptoms (shooting or burning pain, pins and needles) consider selective serotonin
and noradrenaline (norepinephrine) reuptake inhibitors, such as duloxetine
more than a 30% reduction in pain compared with 44% in the
placebo group.16 This was the result of a primary analgesic effect
and not elevation in mood or changes in anxiety or depression.16
These centrally active agents may be useful in subgroups of
people with osteoarthritis of the knee.
Are intra-articular injections beneficial in
osteoarthritis?
Intra-articular corticosteroids are usedwidely in themanagement
of osteoarthritis of the knee. A Cochrane review found that the
reduction in pain lasts for only one to two weeks.17 Given this
short duration of benefit, the cost, and the potential adverse
effects, their use may not be merited in a chronic disease such
as osteoarthritis. Despite their appeal for use in patients with
clinical features of inflammation (such as a large effusion), the
evidence to support this is limited. However, they do have a
role in patients who also have pseudogout and calcium
pryophosphate dihydrate crystals.
Intra-articular injections of viscosupplements (hyaluronic acid)
usually given weekly for three to five weeks, have been
extensively researched. A recent meta-analysis found that trials
are generally of low quality and that viscosupplementation is
associated with a small and clinically irrelevant reduction in
pain and an increased risk of serious adverse events.18 A recent
RCT showed amarked carryover effect for at least one year and
that symptoms improved between cycles, compared with
placebo, suggesting that repeated injection cycles might be
effective.19
New drugs for osteoarthritis of the knee
Newer analgesics, including nerve growth factor inhibitors, are
being developed. High quality RCTs have shown that these
drugs reduce pain in osteoarthritis of the knee.20 However, this
optimism has been clouded by potential safety concerns—a
small number of patients treated with tanezumab have developed
rapid joint destruction.w14
Unfortunately, none of the drugs used in osteoarthritis of the
knee has convincing structural disease modifying efficacy. New
drugs are being developed for osteoarthritis, with trials mainly
testing pro-anabolics (growth factors and hormones), with a
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modest selection of anti-catabolics (interleukin 1, inhibitor of
κB kinase (IκK)), and inducible nitric oxide synthase inhibitors)
and cell therapy (mainly mesenchymal stem cells from bone
marrow or adipose tissue).w15
What is the evidence for glucosamine and
other complementary medicines?
The most commonly used alternative treatment is glucosamine.
In RCTs, glucosamine has a similar effect to placebo on pain,
with industry independent trials showing smaller effects than
commercially funded ones.5 Evidence for a possible structure
modifying effect remains controversial. In contrast, a
meta-analysis (just three RCTs of two years’ duration) found
that chondroitin had a small effect on symptoms and structure
(effect size 0.23).21 A Cochrane review of herbal therapy in
osteoarthritis found two studies with promising results for
avocado soybean unsaponifiables,22 and there is some low level
evidence of efficacy for diacerein, rosehip powder, and
methylsufonylmethane.5 However, high quality trials are
urgently needed before any conclusions can be drawn about the
usefulness of such treatments. American College of
Rheumatology guidelines conditionally recommend that
healthcare providers do not use nutritional supplements (such
as glucosamine) or topical capsaicin.7
What is the role of surgery?
The surgical treatment of choice depends mainly on symptoms,
disability, radiographic severity, and the patient’s age. The
AmericanAcademy of Orthopaedic Surgeons recommends that
arthroscopic lavage or debridement (or both) and meniscal
resection be performed only in patients with mechanical
symptoms, such as sudden onset of inability to fully extend the
knee or repeated disabling catching or locking.23 This operation
has no demonstrable effect on pain in osteoarthritis of the knee,
with the latest RCT showing similar benefits to optimised
physical and medical treatment.24
Joint arthroplasty is reserved for patients with severe disease
defined as persistent moderate to severe pain, functional
limitation, and reduced quality of life despite optimal
conservative treatment, together with radiological disease.
Patients should be referred to an orthopaedic surgeon at the time
when joint replacement is needed and preferably before
substantive functional decline has occurred because this may
not be regained after surgery. Although there are no RCTs,
higher quality prospective studies of consecutive unselected
patients find that joint arthroplasty is generally successful, with
80% of patients reporting reductions in pain.w16 Weight loss
before surgery is important because obesity increases the risk
of surgical complications and is associated with poorer longer
term outcomes.w17 Preoperative exercise for two to three months
can optimise the physical status of patients awaiting joint
replacement. It is not clear whether this enhances postoperative
functional recovery—a recent meta-analysis of 12
quasi-randomised or randomised controlled trials found no
benefits.w18 However, the authors thought that the exercise
programmes in these trials had poor therapeutic validity and
that this may have masked the potential benefits.
In patients under 60 years, the main concern in performing joint
arthroplasty is implant wear because revision arthroplasty is
less successful than primary arthroplasty. Although there is no
definitive answer as to how young is too young for this surgical
procedure, the decision should be based on whether benefits
outweigh risks for each individual. Only low impact activities
such as cycling, swimming, and walking are recommended after
joint arthroplasty because implant wear seems to be partly
related to the amount and type of activity. An alternative
operation in younger or more active patients with
unicompartmental disease is a high tibial osteotomy, which
decreases symptoms, slows down the osteoarthritis process, and
delays the need for arthroplasty by unloading the osteoarthritic
compartment. A recent meta-analysis of cohort studies found
that nine to 12 years after a valgus high tibial osteotomy only
16% of patients had needed joint arthroplasty.25
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Tips for non-specialists
Osteoarthritis of the knee can be reliably diagnosed using clinical signs and symptoms
Screen for the presence of comorbidities such as depression and anxiety and treat if present; consider using duloxetine if depression
and neuropathic symptoms present
Although there is no cure, tell patients that disease does not always progress, radiographic findings do not relate to symptoms, and
many effective treatments are available
Take a patient centred multidisciplinary approach and encourage patients to self manage their condition
All patients should exercise regularly regardless of the severity of symptoms or radiographic changes; a combination of strengthening
and aerobic exercise is recommended. Aquatic exercise may be useful for some people.
Advise against high impact physical activities and sports that involve twisting and repetitive loading
Help patients who are overweight or obese to lose weight—a goal of at least 5% of body weight is recommended
Consider referral to skilled therapists to help with physical, dietary, and psychological interventions where appropriate
Start with paracetamol (caution with maximal dose) or non-steroidal anti-inflammatory drugs (NSAIDs), but take into account gastrointestinal
and cardiovascular safety concerns and comorbidities. Consider topical NSAIDs in patients over 75 years
Arthroscopic surgery is not useful for treating pain and is reserved for patients with mechanical symptoms, such as locking or catching
Consider referral to an orthopaedic surgeon when patients have severe symptoms, have failed conservative management, and joint
replacement is needed—preferably before substantive functional decline has occurred
Questions for future research
How can we maximise adherence to conservative management options such as exercise?
Can load modifying interventions, such as braces, modified footwear, and gait retraining, slow down disease progression?
How can we improve the uptake of optimal management by healthcare professionals?
What models of care are most effective and cost effective in managing people with osteoarthritis of the knee in different settings?
What is the efficacy of the various complementary and alternative medicines available?
What are the barriers to the implementation of primary prevention measures, such as injury prevention and weight reduction?
Can we identify an effective and safe pain relieving modality?
Can we avoid long term systemic toxicity and identify people at risk of rapid structural progression?
What single or composite of synovial joint structure(s) (cartilage, bone, meniscus, synovium, or muscle) should be the target of structure
modifying interventions?
Additional educational resources
Resources for healthcare professionals
Osteoarthritis Research Society International (www.oarsi.org)—Recent OARSI guidelines on the management of knee osteoarthritis,
together with educational resources, meetings, and a slide library
National Institute for Health and Clinical Excellence (www.nice.org.uk)—Recent NICE guidelines on the management of knee osteoarthritis
European League against Rheumatism (www.eular.org)—Recent EULAR guidelines and educational resources, including videos on
physical examination of patients with musculoskeletal conditions
American Academy of Orthopaedic Surgeons (www.aaos.org)—Recent AAOS treatment guidelines for osteoarthritis and educational
resources
American College of Rheumatology (www.rheumatology.org)—Updated treatment guidelines for osteoarthritis released in April 2012
Resources for patients
Arthritis Foundation USA (www.arthritis.org)—Education for the public, patients, and health professionals
Arthritis Care United Kingdom (www.arthritiscare.org.uk)—Education for the public, patients, and health professionals
10 000 Steps (www.10000steps.org.au)—Free health promotion programme that encourages the use of step counting pedometers to
help monitor and increase daily physical activity
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Table
Table 1| Comprehensive assessment of patients with osteoarthritis of the knee and practical implications for management
Practical implicationsAssessment elements
Helps with differential diagnosis and establishes whether radiography andmagnetic resonance imaging
are needed (box 2). Neuropathic symptoms (shooting, burning pain, and pins and needles) may
indicate need for a centrally active agent. Changes in pain allow assessment of treatment response.
If patient has disabling locking or catching consider orthopaedic referral. If giving way and laxity,
consider a gait aid, physiotherapy for muscle strengthening, and referral to an orthotist for bracing. If
knee malalignment, bracing may be beneficial
Joint symptoms and signs such as joint pain, giving way,
stiffness, locking or catching, effusion, range of motion,
tenderness on palpation, joint laxity, knee alignment in
standing
Influence contraindications and precautions for treatment, in particular prescription of drugs (box 4)Comorbidities such as cardiovascular disease, diabetes,
peptic ulcer, renal, liver disease, depression
If difficulty with walking, function, balance, or more than 1 fall in past 12 months, consider gait aid,
attention to footwear, and referral to a physiotherapist for treatment including exercise prescription
and manual therapy. If a varus thrust is seen during walking (visible dynamic worsening of varus
alignment during stance phase), consider referral to a physiotherapist for exercise programme and
possibly orthotist for bracing
Functional ability, activities of daily living (such as walking,
stair climbing, sit to stand, balance), and history of falls
If weak, prescribe muscle strengthening exercises—consider referral to a physiotherapist or exercise
specialist
Muscle mass and strength, particularly of the quadriceps
If abnormalities, consider referral to a podiatrist for orthotics and footwear adviceFoot posture
If mood disorder present, consider referral to psychologist or prescription of antidepressants such as
duloxetine. If difficulty coping or participating, consider referral to appropriate allied health practitioner
(such as a psychologist, occupational therapist, social worker) or relevant self help groups for peer
support
Psychosocial factors, such as mood disorders (depression
and anxiety), sleep, social support, ability to cope,
participation in leisure activities, relationships, and
employment
Facilitates a patient centred approach to management and communication that is tailored to patient’s
needs and goals. Ensure that the patient understands the disease process, has realistic expectations,
and participates in treatment decision making by providing education, information, and resources.
Consider referral to a self management programme
Patient’s knowledge, expectations, and goals
If body mass index is >25 or waist is >80 cm (women) or >94 cm (men), counsel about weight loss
through both diet and exercise (aerobic and strengthening). If possible, refer to a dietitian for nutritional
assessment and weight loss support. Weight loss programmes should aim for a 5-10% reduction
Overweight or obesity (weight, body mass index, and waist
girth)
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Figure
Fig 1 Risk factors for osteoarthritis of the knee and related disability. Modified from Suri and colleagues,w3 with permission
from Elsevier and the American Academy of Physical Medicine and Rehabilitation
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